Skip to main content

Omniseq expects international growth through new cancer test

The new test uses immune profiling and molecular profiling, giving cancer doctors more data to find the right therapies and clinical trial opportunities.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.